Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
ICD-10 F13.150 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions.
F13.150 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to a psychotic disorder that manifests with delusions. This condition typically arises when individuals misuse medications such as benzodiazepines or barbiturates, which are commonly prescribed for anxiety or sleep disorders. The abuse can result in significant alterations in mood, perception, and cognition, culminating in delusions—false beliefs that are firmly held despite contradictory evidence. Patients may exhibit paranoia, hallucinations, or other psychotic symptoms, complicating their clinical picture. Treatment often requires a multidisciplinary approach, including detoxification, psychiatric evaluation, and long-term rehabilitation strategies to address both the substance use disorder and the underlying mental health issues. Proper documentation and coding are crucial for effective treatment planning and reimbursement.
Comprehensive psychiatric evaluation, including history of substance use, mental status examination, and treatment plan.
Patients presenting with acute psychosis following sedative use, chronic users seeking help, or those with co-occurring disorders.
Careful assessment of the patient's substance use history and mental health status is essential for accurate diagnosis and treatment.
Detailed substance use history, assessment of withdrawal symptoms, and treatment response.
Patients undergoing detoxification, those in rehabilitation programs, or individuals with a history of multiple substance use disorders.
Integration of mental health treatment with addiction recovery strategies is crucial for successful outcomes.
Used for follow-up visits for patients diagnosed with F13.150.
Document the patient's mental status, substance use history, and treatment response.
Psychiatrists should ensure comprehensive evaluations are documented to support the complexity of care.
F13.150 includes the presence of delusions as part of the psychotic disorder, while F13.149 does not specify delusions, indicating a less severe presentation of psychotic symptoms.
